1. Home
  2. LW vs SYRE Comparison

LW vs SYRE Comparison

Compare LW & SYRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lamb Weston Holdings Inc.

LW

Lamb Weston Holdings Inc.

HOLD

Current Price

$42.06

Market Cap

5.9B

ML Signal

HOLD

Logo Spyre Therapeutics Inc.

SYRE

Spyre Therapeutics Inc.

HOLD

Current Price

$74.58

Market Cap

6.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LW
SYRE
Founded
1950
2013
Country
United States
United States
Employees
10100
N/A
Industry
Packaged Foods
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.9B
6.3B
IPO Year
2016
2015

Fundamental Metrics

Financial Performance
Metric
LW
SYRE
Price
$42.06
$74.58
Analyst Decision
Hold
Strong Buy
Analyst Count
7
12
Target Price
$44.14
$85.08
AVG Volume (30 Days)
1.5M
1.3M
Earning Date
04-01-2026
05-08-2026
Dividend Yield
3.53%
N/A
EPS Growth
N/A
N/A
EPS
1.29
N/A
Revenue
N/A
N/A
Revenue This Year
$4.26
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$33.39
N/A
Revenue Growth
N/A
N/A
52 Week Low
$37.62
$13.93
52 Week High
$67.07
$76.00

Technical Indicators

Market Signals
Indicator
LW
SYRE
Relative Strength Index (RSI) 44.42 67.34
Support Level $41.41 $30.39
Resistance Level $42.69 $75.28
Average True Range (ATR) 1.35 4.20
MACD -0.15 -0.59
Stochastic Oscillator 12.38 85.49

Price Performance

Historical Comparison
LW
SYRE

About LW Lamb Weston Holdings Inc.

Lamb Weston is North America's largest and the world's second-largest producer of branded and private-label frozen potato products, both by volume and value. The company's portfolio is anchored by french fries, but it also sells sweet potato fries, tater tots, diced potatoes, mashed potatoes, hash browns, and chips. Roughly two thirds of revenue comes from its home market of North America, with none of the other 100 countries the company sells into representing a significant share. McDonald's is Lamb Weston's single-largest customer at 15% of fiscal 2025 sales, with no other company representing more than 10%. Lamb Weston became an independent company in 2016 when it was spun off from Conagra.

About SYRE Spyre Therapeutics Inc.

Spyre Therapeutics Inc is a clinical-stage biotechnology company pioneering long-acting antibodies and antibody combinations to redefine the standard of care for inflammatory bowel disease (IBD) and rheumatic diseases. Spyre's pipeline includes extended half-life antibodies targeting α4β7, TL1A, and IL-23 in development as monotherapies and pair-wise combinations. It has a single reportable segment, which is the development of biopharmaceutical products for the treatment of patients with IBD and other immune-mediated disease.

Share on Social Networks: